Medicine Man Technologies Q1 2024 GAAP EPS $(0.24) Misses $(0.16) Estimate, Sales $41.601M Beat $39.834M Estimate
Portfolio Pulse from Benzinga Newsdesk
Medicine Man Technologies (OTC:SHWZ) reported a Q1 2024 GAAP EPS of $(0.24), missing the $(0.16) estimate by 50%. However, sales of $41.601M beat the $39.834M estimate, marking a 4.44% increase.
May 15, 2024 | 8:12 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Medicine Man Technologies reported a Q1 2024 GAAP EPS of $(0.24), missing the $(0.16) estimate by 50%. However, sales of $41.601M beat the $39.834M estimate, marking a 4.44% increase.
The significant miss on EPS by 50% is likely to negatively impact the stock price in the short term, despite the positive sales performance. Investors often react more strongly to earnings misses than to sales beats.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100